EGFR and neoplasm: The inhibitory effect of PTS on the in-tumor mTOR pathway resulted in the downregulation of TGF-β, CD44, VEGF, and EGFR, which would have had the effect of retarding tumor-cell migration and invasion, thus reducing the potential risk of metastasis.